VC-Backed Biotech, Midsize Bank Boost Growing IPO Pipeline
Venture-backed gene-editing biotech Intellia Therapeutics Inc. and middle-market bank Midland States Bancorp filed initial public offerings Monday, each seeking to raise $120 million, adding to a growing pipeline of IPO candidates....To view the full article, register now.
Already a subscriber? Click here to view full article